관련 키워드대원제약3분기 실적흑자전환약가 인하호흡기 질환 수요 둔화문대현 기자 How Korea's Medical Device R&D is Shaping the Future of Healthcare: Insights from GBF 2026K-Beauty Companies Target Global Distribution Networks in Hong Kong With Support for 10 SMEs